The Scientist

» Parkinson's disease

Most Recent

image: Say

Say "Aaaah"

By | August 1, 2014

Scientists aim to remotely monitor Parkinson’s through voice recordings.

0 Comments

image: Lozano on DBS

Lozano on DBS

By | November 1, 2013

Neurosurgeon Andres Lozano discusses deep-brain stimulation in this TEDx talk.

0 Comments

image: Tuning the Brain

Tuning the Brain

By | October 28, 2013

Deep-brain stimulation is allowing neurosurgeons to adjust the neural activity in specific brain regions to treat thousands of patients with myriad neurological disorders.

2 Comments

image: Contributors

Contributors

By | October 1, 2013

Meet some of the people featured in the October 2013 issue of The Scientist.

0 Comments

image: Smell and the Degenerating Brain

Smell and the Degenerating Brain

By | October 1, 2013

An impaired sense of smell is one of the earliest symptoms of Alzheimer’s, Parkinson’s, and some other neurodegenerative diseases. Could it be a useful diagnostic tool?

7 Comments

image: A Root Cause of Parkinson’s

A Root Cause of Parkinson’s

By | November 15, 2012

Misfolded α-synuclein proteins promote the spread of Parkinson’s pathology in mouse brains.

1 Comment

image: New Culprit for Parkinson’s?

New Culprit for Parkinson’s?

By | October 17, 2012

Scientists use human stem cells to show that nuclear defects may play a role in Parkinson’s disease, and suggest a way to reverse the problem.

4 Comments

image: Eyes: a Window to the Diagnosis

Eyes: a Window to the Diagnosis

By | September 6, 2012

Researchers use characteristic differences in eye movements to identify patients with deficits in neurological function.

2 Comments

image: Parkinson’s Researcher Fabricated Data

Parkinson’s Researcher Fabricated Data

By | June 29, 2012

Neuroscientist Mona Thiruchelvam agrees to retract two studies linking neurodegeneration to pesticides.

31 Comments

image: Parkinson's Vax Enters Clinical Trials

Parkinson's Vax Enters Clinical Trials

By | June 7, 2012

Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Grass Routes
    Features Grass Routes

    Researchers are discovering a suite of new locations and functions of endocannabinoid receptors that play roles in sickness and in health.

  3. Studies Retracted After UCLA Investigation
  4. Trump Nominates Sam Clovis to Lead USDA Research
AAAS